Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    LM PAY

    MCap

    EUR24m

    Last close

    EUR37.60

    ▲ 4.00 (11.90%)

    Pathos Communications

    MCap

    GBP18m

    Last close

    GBP0.26

    ▲ 2.50 (10.64%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Targovax (NO: TRVX)

Last close As at 06/08/2026

—

— 0.00 (0.00%)

Market capitalisation

—

Edison Investment Research is terminating coverage on Targovax. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Targovax — Growing list of collaborations and more data in H2

Healthcare | Update

Targovax — Confirmatory 12-month mesothelioma update

Healthcare | Update

Targovax — ONCOS-102 plus durvalumab trial in spotlight

Healthcare | Update

Targovax — More data in 2020 from both clinical trials

Market Data

Share Price —
Market Cap —
52-Week High —
52-Week Low —
% Change 1M
% Change 6M —
% Change 12M
Ave. Daily Volume 1yr —
Visit Website

Sector

Healthcare

Update

Healthcare

Targovax — Key catalysts in 2018

Initiation

Healthcare

Targovax — Priming immune response in anticancer combos